- Home
- Equipment
- asia middle east
- cancer therapies
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Applications
- microbiota for Clinical Studies
- Radioactive Drugs for Diagnostics
- Radioactive Drugs for Therapeutics
- Drug Dolution for Liver Metastases
- Drug Dolution for Gastric Cancer
- Actionable Molecular Diagnostic System for Physicians
- Intraoperative Radiation Therapy (IORT) System - Electron Therapy for Skin Cancer
- Intraoperative Radiation Therapy (IORT) System for Flash Radiotherapy
- Intraoperative Radiation Therapy (IORT) System for Pancreatic Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Breast Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Single-Fraction APBI
- Intraoperative Radiation Therapy (IORT) System for Surgical Oncologists
- Intraoperative Radiation Therapy (IORT) System for Radiation Oncologists
- Intraoperative Radiation Therapy (IORT) System for Hospital Administrators
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
- Remote Patient Monitoring Solution for Remote Patient Monitoring
- Remote Patient Monitoring Solution for Revenue Cycle Management
- Remote Patient Monitoring Solution for EHR Integration
- Liposomes - Hollow Nanospheres for Gene Therapy
- Liposomes - Hollow Nanospheres for Cancer Therapy
- Liposomes - Hollow Nanospheres for Ocular Drug Delivery
- Liposomes - Hollow Nanospheres for Brain Drug Delivery
- Liposomes - Hollow Nanospheres for Vaccines
- Liposomes - Hollow Nanospheres for Immunomodulating Response
- Liposomes - Hollow Nanospheres for Tissue Engineering
- Exosomes - Extracellular Vesicles for Validation and Quality Control
- Exosomes - Extracellular Vesicles for Cancer Treatment
- Exosomes - Extracellular Vesicles for Immunomodulating Response
- Exosomes - Extracellular Vesicles for Molecular Therapy
- Exosomes - Extracellular Vesicles for Brain Drug Delivery
- Exosomes - Extracellular Vesicles for Ocular Drug Delivery
Cancer Therapies Equipment & Supplies In Asia Middle East
364 equipment items found
by:Theralase Technologies Inc. based inToronto, ONTARIO (CANADA)
Theralase is laser focused on advancing the cutting-edge Anti-Cancer Therapy (“ACT”) towards commercialization, providing an alternative treatment methodology for Non-Muscle Invasive Bladder Cancer (“NMIBC”) patients globally. Theralase is dedicated to safely and effectively destroying cancer through the ...
by:B dot Medical Inc. based inEdogawa-ku, JAPAN
We are trying to overturn the image that society has of radiotherapy and proton therapy with our innovative technology. We are developing proton therapy with the hope of making it accessible to all cancer ...
Premium
Manufactured by:Vobis LLC based inEaston, PENNSYLVANIA (USA)
We have developed proprietary lipid based nano technologies that have potential benefits in different therapeutic areas including targeted cancer therapy, DNA Vaccination and liver diseases. Here are the some of the highlights related to our LNP and liposomal experience including type of liposomes and techniques. ...
Manufactured by:Emosis Diagnostics SAS based inIllkirch-Graffenstaden, FRANCE
Primary aim is in assessing procoagulant states associated with cancer and cancer therapies, to inform physician’s decision making on initiating, pursuing or stopping anticoagulant prophylaxis in cancer patient. ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
Starpharma’s DEP® technology provides enhanced therapeutic benefits to Antibody Drug Conjugates (ADCs) including greater homogeneity, site specific attachment, and higher drug antibody ratio (DAR), than conventional ADC approaches. The use of ADCs is an innovative and cutting-edge area in cancer therapy that continues to grow, and Starpharma has a ...
by:Verb Biotics based inBoston, MASSACHUSETTS (USA)
Yso5 is a discovery-stage program leveraging a specific keystone gut bacteria (undisclosed) to potentiate the effects of Immune Checkpoint Blockade (ICB) drugs. The field of cancer therapy has been revolutionized by the use of immunotherapy. The microbiome breakthrough science today paves the way for innovative biotherapies to potentiate the effectiveness of ...
Manufactured by:Adaptimmune LLC based inPhiladelphia, PENNSYLVANIA (USA)
Our goal is to revolutionize cancer therapy on a global basis by developing TCR T-cell therapies (called SPEAR T-cells) with the potential to treat a wide range of cancer types and patients. Our TCR T-cell therapies have advantages over other immune therapies and cancer ...
Manufactured by:Panagene Inc. based inDaejeon, SOUTH KOREA
KRAS mutation is found in several cancers such as pancreatic cancer, colorectal cancer, lung cancer, biliary tract cancer and thyroid cancer. The existence of KRAS mutations is often related with a prognostic marker to drug response. For example, KRAS mutation is considered a strong prognostic ...
Manufactured by:MuseChem based inPaoli, PENNSYLVANIA (USA)
Additionally, it is studied for its neuroprotective effects in neurodegenerative diseases and its potential as a photosensitizer in cancer therapy. Its wide range of uses makes it a versatile compound in clinical and research ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
NMS-P118 is a potent, orally available, and highly selective PARP-1 Inhibitor for cancer ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a histone protein, leading to the suppression of gene expression. Some cancers depend on an abnormal pattern of gene expression and re-direct EZH2 to genes that become abnormally repressed. Cancer cells with these abnormal gene expression programs may be more resistant to ...
Manufactured by:Mersana Therapeutics based inCambridge, MASSACHUSETTS (USA)
Once ADCs release their cytotoxic payload into targeted cells, the drug is often able to cross cell membranes, entering and potentially killing neighboring cells whether those cells are cancerous or not. This effect is called bystander-killing, which is advantageous when bystander cells are cancerous but toxic if the cytotoxic drug is able to enter adjacent ...
Manufactured by:Sirtex Medical Inc. based inWoburn, MASSACHUSETTS (USA)
SIR-Spheres Y-90 resin microspheres are a medical device used in selective internal radiation therapy (SIRT), primarily for the treatment of inoperable liver tumors. These microspheres are based on yttrium-90, a radioactive isotope, and are injected directly into the hepatic artery, enabling targeted radiation delivery. The primary goal is to deliver high doses of radiation to ...
Manufactured by:Galvanize Therapeutics, Inc. based inRedwood City, CALIFORNIA (USA)
The system utilizes the INUMI Flex needle for endoscopic applications, providing a precise and predictable ablation zone with minimal interference from heat sinks. The technology shows promising synergies with standard cancer therapies by potentially activating an immune response through the release of antigens from destroyed tumor cells. However, its clinical ...
by:IBA based inLouvain-La-Neuve, BELGIUM
Proteus®PLUS is a unique proton therapy solution for leading cancer centers striving to meet a large and growing patient base's treatment needs while further advancing your clinical reputation in cancer care. Its cutting-edge features can be configured into a tailored solution to meet your research, clinical, and business objectives. ...
Manufactured by:Bioprojet based inParis, FRANCE
Oral follow-up treatment of injectable therapy for malignant hypercalcaemia, Palliative treatment of osteolysis of malignant origin with or without hypercalcaemia, in conjunction with specific cancer treatment, In the event of hypercalcaemia, the treatment must be associated with optimal rehydration. ...
Manufactured by:Shengkang Fine Chemical Co., Ltd based inHong Kong, CHINA
Name Erlotinib. Molecular Formula C22H23N3O4. Molecular Weight 393.44. CAS Registry Number 183321-74-6. Application Treatment of pancreatic cancer. ...
Manufactured by:TxinnoBioscience Inc. based inYongin-si, SOUTH KOREA
Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. The first one is defined as tumor-intrinsic factors which are either genes or signaling pathways of tumor cells to directly control tumor cell proliferation or survival. Corresponding assets are ULK1 inhibitor, target S inhibitor and target Y inhibitor related to RAS signaling ...
Manufactured by:Vivesto AB based inSolna, SWEDEN
XR-18 is a research effort based on the XR-17 technology platform intended to provide enhanced properties that improve clinical formulations and applications of active pharmaceutical ingredients (APIs) for cancer treatment. This effort has recently generated promising data including: Addition of components to existing XR-17 formulation improving certain properties. Synthesis of novel excipients ...
Manufactured by:AJ Vaccines A/S based inKøbenhavn, DENMARK
VesiCulture (BCG Culture) For the treatment of Bladder ...